This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West
Delivered as a Hybrid Event
February 27 - March 2, 2023San Diego Convention Center

Senthil Ranganathan
Vice President, Technical Operations at Athersys


Senthil heads the Technical Operations at Athersys where he is accountable for process development, MSAT and the CMC commercialization of Athersys’ stem cell therapies. Over the course of his career spanning 15+ years, Senthil has held positions of progressively greater responsibilities in CMC, having started his career as a bench scientist in process development. He has worked at both innovator companies and at CMOs, large and small.

Senthil has a B.Sc. degree in Microbiology from the Bangalore University and a Ph.D in Biochemistry from the Loyola University Chicago.

Agenda Sessions

  • The Path to Commercialization of an Allogeneic Stem Cell Therapy: a MultiStem© Perspective